Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes.

Eun Hye LeeSeung Hyun YongAh Young LeemSang Hoon LeeSong Yee KimKyung Soo ChungJi Ye JungMoo Suk ParkYoung Sam KimJoon ChangYoung Ae Kang

Published in: Open forum infectious diseases (2019)

Overall, 76.6% of MDR TB patients had successful treatment outcomes. Effective drug combinations and appropriate use of new drugs may improve treatment outcomes of FQ-R MDR and XDR TB. Poor clinical outcomes were more related to the patients' general condition rather than FQ resistance or XDR.

Keyphrases

drug resistant
multidrug resistant
end stage renal disease
ejection fraction
mycobacterium tuberculosis
newly diagnosed
chronic kidney disease
pulmonary tuberculosis
hepatitis c virus
human immunodeficiency virus
electronic health record